99 results on '"Bruno, Cosimo Marcello"'
Search Results
2. Acid-base disturbance in liver cirrhosis
3. Gli squilibri idroelettrolitici e acido-base in medicina interna. 2° edizione
4. Necrotizing Panniculitis as an Uncommon Manifestation of Acute Pancreatitis
5. Comparison between bicarbonate-based and Stewart methods to assess metabolic acid-base disorders in internistic patients. A pilot study
6. Evidence for harm reduction in COPD smokers who switch to electronic cigarettes
7. Tubular Handling of Uric Acid and Factors Influencing Its Renal Excretion: A Short Review
8. ON-TREATMENT HBsAg DECLINE IS ASSOCIATED WITH SUBSEQUENT HBsAg REDUCTION IN HBeAg NEGATIVE CHRONIC HEPATITIS B
9. INFLAMMATORY AND ANGIOGENIC FACTORS SERUM LEVELS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
10. Acid-Base Disorders in Patients with Chronic Obstructive Pulmonary Disease: A Pathophysiological Review
11. COMPLICATION AND HOSPITALISATION AFTER PERCUTANEOUS LIVER BIOPSY: A COHORT STUDY OF 12 YARS
12. Steatohepatites Influence The Cardiovascular And Diabetus Mellitul Risk Profile
13. Erythropoietin alpha 40.000 IU increases haemoglobin levels and improves sustain virological response in combination therapy with peg-interferon/ribavirin in chronic hepatitis C
14. Suboptimal Endogenous Erythropoietin Response In Chronic Hepatitis C Patients During Peg-Interferon And Ribavirin Treatment
15. Association Between Diabetes Mellitus, Hepatic Steatosis And Fibrosis In Chronic Hepatitis C Patients
16. THE COMPARATIVE STUDY OF TERLIPRESSIN AND ALBUMIN FOR TYPE-1 HEPATORENAL SYNDROME (HRS) IN PATIENTS WITH CIRRHOSIS AND SPONTANEOUS BACTERIAL PERITONITIS (SBP) VS CIRRHOSIS ALONE
17. URSODEOXYCHOLIC ACID AND SIMVASTATIN IN PATIENTS WITHNONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME
18. Sustained Virological Response reduces insulin resistance in patients with genotype 1 Chronic Hepatitis C
19. Epoetin alpha improves the response to antiviral treatment in HCV-related chrinic hepatitis
20. Co-administration ezetimibe/simvastatin teraphy decrease the supersaturation in gallbladder bile and prevent cholesterol gallstones formation
21. TRIGLYCERIDE SERUM LEVELS WERE INDEPENDENTLY ASSOCIATED WITH SERUM AMINOTRANSFERASE LEVELS IN NONALCOHOLIC FATTY LIVER DISEASE PATIENTS WITH OBESITY
22. POST-LOAD INSULIN RESISTANCE IS AN INDEPENDENT PREDICTOR OF HEPATIC FIBROSIS IN DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
23. CO-ADMINISTRATION EZETIMIBE/SIMVASTATIN TERAPHY DECREASES THE SUPER-SATURATION IN GALLBLADDER BILE AND PREVENT CHOLESTEROL GALLSTONES FORMATION
24. VISCERAL ADIPOSE TISSUE AREA AS INDEPENDENT RISK FACTOR OF ELEVATED ALANINE AMINOTRANSFERASE SERUM LEVELS
25. Efficacy and safety of paroxetine for prevention of depressive symptoms induced by peginterferon alpha-2a and ribavirin in chronic hepatitis C. A double-blind, randomized,placebo controlled study
26. Visceral adipose tissue area as independent risk factor of elevated alanine aminotransferase
27. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndroe
28. Valutazione e possibile significato dei livelli plasmatici di interleukina-10 nell’epatite cronica da virus C
29. Rapid virological response is predictor of sustained virological response in patients with chronic hepatitis C treated with peginterferon alfa-2a plus ribavirin
30. Gli squilibri idroelettrolitici e acido-base in Medicina Interna
31. Identification of genotypes and detection of hepatitis B virus resistance mutations
32. La metalloproteinasi-2 è un marker indiretto di citonecrosi e fibrosi epatica nell’epatite cronica HCV-correlata
33. Il consumo di alcol in gravidanza aumenta il rischio di parto pretermine e aborto spontaneo
34. A therapeutic education and medical support program improves adherence to therapy with peg-interferon plus ribavirin therapy and increases sustained virological response in patients with chronic hepatitis C
35. Considerazioni epidemiologiche sull’attività di ricovero di una U.O.C. di Medicina Interna della Sicilia orientale
36. Livelli circolanti di interleuchina-10 in soggetti affetti da epatopatia cronica:studio pilota
37. Peg-interferon alfa 2a versus lamivudina nel trattamento dell'epatite cronica HBeAg negativa/HBeAb positiva. Studio pilota
38. Pegylated-interferon and ribavirin therapy of HCV-related type II mixed cryoglobulinemia
39. Ruolo di MMP-2 e MMP-9 come indicatori prognostici indiretti nella progressione delle epatopatie croniche
40. Peg-interferone alfa 2a versus lamivudina nel trattamento dell'epatite cronica HBeAg negativa/HBeAb positiva.Studio pilota
41. Infezione da HAV in pazienti con epatite cronica HCV correlata
42. Livelli circolanti di interleuchina-10 in soggetti affetti da epatopatia cronica: studio pilota
43. Infezione da HAV in pazienti con epatite cronica HCV-correlata
44. Ferro e ferrodeplezione nell'epatite cronica HCV-correlata
45. Una inusuale associazione:epatite autoimmune tipo I - ipertensione polmonare idiopatica
46. Ferro e ferrodeplezione nell'epatite cronica HCV-correlata.Studio pilota
47. Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers
48. Riduzione dell’incidenza di HCC in soggetti con cirrosi epatica HCV-correlata
49. Eritropoietina nel trattamento dell’anemia secondaria a terapia con interferone peghilato e ribavirina
50. Circulating erytropoietin in diabetes mellitus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.